Palforzia (12 Mg Daily Dose)
Palforzia (12 MG Daily Dose) 45 Capsules Sprinkle Therapy Pack
What is Palforzia (12 Mg Daily Dose)?
Palforzia (12 mg daily dose) is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts. Approved for children ages 4 through 17 with a confirmed diagnosis of peanut allergy, Palforzia is a part of a structured treatment regimen that progressively increases the body's tolerance to peanuts. The treatment must be initiated under the supervision of a healthcare provider trained in the management of severe allergic reactions.Side Effects
- Throat irritation and itching
- Abdominal pain
- Cough
Warnings
- Patients with uncontrolled asthma should not use Palforzia
- Palforzia can cause severe allergic reactions including anaphylaxis, which can be life-threatening
- Palforizia should only be administered in a healthcare setting under the supervision of a healthcare provider equipped to manage anaphylaxis
- Do not administer Palforzia to patients with a history of eosinophilic esophagitis and other eosinophilic gastrointestinal disease
Prescription savings · · ·
- Throat irritation and itching
- Abdominal pain
- Cough
- Hives
- Nausea and vomiting
- Anaphylaxis (severe allergic reaction)
- Patients with uncontrolled asthma should not use Palforzia
- Palforzia can cause severe allergic reactions including anaphylaxis, which can be life-threatening
- Palforizia should only be administered in a healthcare setting under the supervision of a healthcare provider equipped to manage anaphylaxis
- Do not administer Palforzia to patients with a history of eosinophilic esophagitis and other eosinophilic gastrointestinal disease
Palforzia (12 Mg Daily Dose) Coupons & Prices
Palforzia (12 MG Daily Dose) 45 Capsules Sprinkle Therapy Pack
What is Palforzia (12 Mg Daily Dose) ?
Palforzia (12 mg daily dose) is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts. Approved for children ages 4 through 17 with a confirmed diagnosis of peanut allergy, Palforzia is a part of a structured treatment regimen that progressively increases the body's tolerance to peanuts. The treatment must be initiated under the supervision of a healthcare provider trained in the management of severe allergic reactions.
Related Drugs
Browse more medications: starting with P · full A-Z directory · by condition · common drugs
Medical disclaimer: This information is provided for general educational purposes only and is not medical advice. It is not a substitute for professional diagnosis or treatment. Always consult a licensed physician, pharmacist, or other qualified healthcare provider before starting, stopping, or changing any medication or treatment. Never disregard professional medical advice or delay seeking it because of something you read here. If you think you may have a medical emergency, call your doctor or 911 immediately.